| | 332012-40-5 Basic information More.. |
| Product Name: | Telatinib | | Synonyms: | 2-Pyridinecarboxamide, 4-(((4-((4-chlorophenyl)amino)furo(2,3-D)pyridazin-7-yl)oxy)methyl)-N-methyl-;Bay 57-9352;Unii-18p7197Q7j;Telatinib(BAY 57-9352);4-[[[4-[(4-Chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl]oxy]methyl]-N-methyl-2-pyridinecarboxamide;4-((4-(4-chlorophenylamino)furo[2,3-d]pyridazin-7-yloxy)methyl)-N-methylpicolinamide;4-[[[4-[(4-Chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl]oxy]methyl]-N-methyl-2-pyridinecarboxamide Telatinib(BAY57-9352);Telatnib | | CAS: | 332012-40-5 | | MF: | C20H16ClN5O3 | | MW: | 409.83 | | EINECS: | | | Mol File: | 332012-40-5.mol |  |
Use
Telatinib small-molecule inhibitor of vascular endothelial growth factor receptors 2 and 3 (VEGFR-2/-3) and platelet-derived growth factor receptor β tyrosine kinases. Telatinib is used therapeuticall
y in patients with advanced solid tumors.
- Telatinib USP/EP/BP
-
- US $1.10 / g
- 2021-07-07
- CAS:332012-40-5
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons Min
|
|
332012-40-5
Recommend Suppliers |
|